Michael R. Waters
University of Virginia
9 Papers
8 Citations
Michael R. Waters is an academic researcher from University of Virginia. The author has contributed to research in topics: Univariate analysis & Cancer. The author has an hindex of 2, co-authored 9 publications.
Chat about Author
Papers
Stereotactic radiosurgery for the treatment of bulky spine metastases.
Roman O. Kowalchuk,Michael R. Waters,K Martin Richardson,Kelly Spencer,James M. Larner,Jason P. Sheehan,William H McAllister,Charles R Kersh +7 more
TL;DR: SRS can effectively treat bulky metastases to the spine, resulting in improvement of pain with minimal toxicity, and severe pain independently predicts for worse overall survival, indicating that treatment prior to worsening of pain is strongly recommended.
12
Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes
Roman O. Kowalchuk,Michael R. Waters,Sunil W. Dutta,Marie L. Mack,K Martin Richardson,Kelly Spencer,Kara D. Romano,James M. Larner,Jason P. Sheehan,C. Ronald Kersh +9 more
TL;DR: A local control risk stratification model for SBRT to sites of metastatic disease was developed and treatment target and primary tumor were identified as critical factors determining local control.
7
Stereotactic Body Radiation Therapy for Salvage Treatment of Recurrent Non-Small Cell Lung Cancer.
Roman O. Kowalchuk,Michael R. Waters,K Martin Richardson,Kelly Spencer,James M. Larner,Charles R Kersh +5 more
TL;DR: Salvage treatment for recurrent NSCLC with SBRT was effective and well tolerated, particularly after initial treatment with S BRT, and BED ≥80 Gy was predictive of improved LPFS and PFS.
6
A comparison of stereotactic body radiation therapy for metastases to the sacral spine and treatment of the thoracolumbar spine.
Roman O. Kowalchuk,Michael R. Waters,K Martin Richardson,Kelly Spencer,James M. Larner,Jason P. Sheehan,William H McAllister,Charles R Kersh +7 more
TL;DR: SBRT for sacral spine metastases is a distinct disease process than metastases to the thoracolumbar spine, resulting in lower rates of local control and pain improvement.
4
A single-institutional experience with low dose stereotactic body radiation therapy for liver metastases.
Roman O. Kowalchuk,Michael R. Waters,K Martin Richardson,Kelly Spencer,James M. Larner,Charles R Kersh +5 more
TL;DR: Relatively low-dose SBRT for liver metastases demonstrated efficacy and minimal toxicity, even for patients with large tumors or multiple lesions, and this approach may be useful for patients in whom higher-dose therapy is contraindicated or associated with high risk for toxicity.
3